AURX
Nuo Therapeutics IncOTCQB
Healthcare • Biotechnology
Updated 8 days ago
Coverage ready
Portfolio context
Sign in to see your position size
We’ll show you if AURX is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: LOW
0 top institutions tracked
as of 2026-Q2 (filed 2026-08-14)
Insider context
Sentiment: neutral
Last trade: buy 44 days ago
Red flags: 8
Largest 13-F holders · Q2 2026
1 filers reported a long position in AURX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Ancora Advisors LLC | $4.3K | 4.7K | Unchanged |
Get the Full Analysis for AURX
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.